HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The R402Q tyrosinase variant does not cause autosomal recessive ocular albinism.

Abstract
Mutations in the gene for tyrosinase, the key enzyme in melanin synthesis, are responsible for oculocutaneous albinism type 1, and more than 100 mutations of this gene have been identified. The c.1205G > A variant of the tyrosinase gene (rs1126809) predicts p.R402Q and expression studies show thermolabile enzyme activity for the variant protein. The Q402 allele has been associated with autosomal recessive ocular albinism when it is in trans with a tyrosinase gene mutation associated with oculocutaneous albinism type 1. We have identified 12 families with oculocutaneous albinism type 1 that exhibit segregation of the c.1205G > A variant with a known pathologic mutation on the homologous chromosome, and demonstrate no genetic association between autosomal recessive oculocutaneous albinism and the Q402 variant. We conclude that the codon 402 variant of the tyrosinase gene is not associated with albinism.
AuthorsWilliam S Oetting, Jacy Pietsch, Marcia J Brott, Sarah Savage, James P Fryer, C Gail Summers, Richard A King
JournalAmerican journal of medical genetics. Part A (Am J Med Genet A) Vol. 149A Issue 3 Pg. 466-9 (Mar 2009) ISSN: 1552-4833 [Electronic] United States
PMID19208379 (Publication Type: Case Reports, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright2009 Wiley-Liss, Inc.
Chemical References
  • Monophenol Monooxygenase
Topics
  • Albinism, Ocular (enzymology, genetics)
  • Albinism, Oculocutaneous (enzymology, genetics)
  • Alleles
  • Databases, Genetic
  • Family
  • Gene Frequency
  • Genes, Recessive
  • Genetic Variation
  • Humans
  • Monophenol Monooxygenase (genetics)
  • Mutation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: